Media Summary: When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and data were shaping cancer care ... Jay Baum, PhD and Vice President & Head of Translational Medicine at Lead Therapies joins our own Adam Koch, PhD and ... Dan Brennan, senior analyst at TD Cowen, joins CNBC's 'The Exchange' to discuss his price target on
Tempus Next - Detailed Analysis & Overview
When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and data were shaping cancer care ... Jay Baum, PhD and Vice President & Head of Translational Medicine at Lead Therapies joins our own Adam Koch, PhD and ... Dan Brennan, senior analyst at TD Cowen, joins CNBC's 'The Exchange' to discuss his price target on Subscribe to the podcast on your chosen streaming service: Eric Lefkofsky, CEO and founder of ... In this insightful episode of FYI, Eric Lefkofsky, CEO of AI News Flash for May 14, 2026 at 22:00 UTC. Topics: 1. Figma earnings defy AI narrative ...
AI stocks are still taking the world by storm, so when an "AI stock" has an IPO, we're bound to cover it.
![[5/14 22:00] Figma earnings defy AI narrative / BMS-Tempus AI clinical trials](https://i.ytimg.com/vi/fxkjJCuN49U/mqdefault.jpg)
